George Clinical’s deep oncology research expertise was on display during the 2021 ASCO Annual Meeting. Several leaders were featured in sessions during the conference including Drs. Lee Schwartzberg, Ari VanderWalde, Herbert Loong, Ralph Boccia, Timothy Pluard and Jason Chandler.
Schwartzberg is a co-author on 10 different abstracts that were highlighted in sessions during the virtual event including “Impact of clinical trial enrollment on episode costs in the Oncology Care Model (OCM).” Schwartberg and fellow scientific leader VanderWalde are co-authors on “A study evaluating targeted therapies in participants who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response (MyTACTIC)” also selected for the meeting.
Given the back-to-back pace of online conferences, if you or a member of your team was unable to connect with George Clinical during the conference, please reach out to the business development team so they can facilitate a follow up meeting or include you in a future invite-only roundtable session. For more information on these scientific leaders, their abstracts and how George Clinical is supporting oncology studies around the world, please contact Matthew Reabold at [email protected]